Ready 8-Ks
20
Latest filing
April 29, 2026, 7:59 PM ET
Top materiality
0.85
Event mix
earnings ×9 · other_material ×4 · debt ×3
Sentiment
8 pos · 0 neg · 12 neu
Latest earnings
reported 2026-Q2
-
Scotts Miracle-Gro Q2 net sales +5% to $1.46B; adj. EPS $4.53 beats $4.00 YoY
GAAP diluted EPS from continuing ops $4.46 vs $3.78; adjusted EPS $4.53 vs $4.00, up 13%.
-
ScottsMiracle-Gro sells Hawthorne to Vireo for 213M shares plus warrants
Consideration: 213M subordinate voting Vireo Shares and warrants for 80M additional shares.
-
Scotts Miracle-Gro reclassifies Hawthorne as discontinued ops for sale; revises prior financials
Hawthorne business classified as held for sale in Q1 2026; results reclassified as discontinued operations.
-
Scotts Miracle-Gro shareholders approve 2.75M share increase to long-term incentive plan
Shareholders approved amendment to LTIP adding 2,750,000 shares for future equity awards.
-
Scotts Miracle-Gro reports Q1 net loss of $0.83/sh, announces Hawthorne sale to Vireo, $500M buyback
U.S. Consumer net sales $328.5M; GAAP gross margin 25.0% (+90 bps); net leverage improved to 4.03x.
-
Scotts Miracle-Gro refinances $2.0B credit facility; term loan reduced to $500M, maturity extended to 2030
New $2.0B credit facility ($1.5B revolver + $500M term) replaces prior $2.5B facility ($1.5B revolver + $1B term).
-
Scotts Miracle-Gro adopts new RSU award form for executives under LTIP
New form of restricted stock unit award notice effective November 13, 2025.
-
SMG FY2025 adj EPS $3.74, gross margin up 490 bps; guides FY2026 adj EPS $4.15-$4.35
FY2025 adj EPS $3.74 vs $2.29 prior year; GAAP EPS $2.47 vs ($0.61) prior year.
-
Scotts Miracle-Gro extends receivables purchase facility to September 2026
Extended Purchase Termination Date from Sept 1, 2025 to Sept 1, 2026 under Master Receivables Purchase Agreement with JPMorgan Chase.
-
Scotts Miracle-Gro announces board retirement of Lt. Gen. Vines, appointment of Gen. Miller
Lt. Gen. John R. Vines retired July 31, 2025 after 12+ years; stays as Board member emeritus.
-
Scotts Miracle-Gro Q3 GAAP EPS $2.54, adj. EPS $2.59; reaffirms FY guidance
GAAP net income $149.1M ($2.54/diluted share) vs. $132.1M ($2.28) a year ago; non-GAAP adj. $151.5M ($2.59).
-
Scotts Miracle-Gro Q2 GAAP EPS $3.72; adjusted EBITDA $402.8M, reaffirms guidance
Q2 GAAP EPS $3.72 vs $2.74 prior year; adjusted EPS $3.98 vs $3.69.
-
Scotts Miracle-Gro CEO clarifies on CNBC: POS units up double digits in H1; full results Apr 30
CEO Jim Hagedorn on CNBC Mad Money April 25 initially said sales up double digits, then corrected to POS units up double digits.
-
Scotts Miracle-Gro appoints Nick Miaritis to board; say-on-pay vote 30% against
Director Tom Kelly retired Jan 31, 2025 after ~20 years; no disagreement with company.
-
Scotts Miracle-Gro Q1 adj. EBITDA improves $30M; reaffirms FY guidance; lowers interest expense view
Q1 net loss $69.5M ($1.21/sh) vs $80.5M ($1.42/sh) YoY; adj. loss $0.89/sh improved $0.56.
-
Scotts Miracle-Gro reports fiscal 2024 adjusted EPS $2.29, up from $1.21; free cash flow exceeds $1B over two years
Full-year revenue $3.6B flat; U.S. Consumer up 6% to $3.0B; Hawthorne down 37% to $294.7M.
-
Scotts Miracle-Gro appoints Rob Candelino to board of directors
Roberto Candelino, CEO of PetSafe Brands, appointed as Class I director effective Nov 4, 2024.
-
Scotts Miracle-Gro expands receivables facility to $750M, extends through Sep 2025
Program limit increased from $600M to $750M; purchase termination date extended to September 1, 2025.
-
Scotts Miracle-Gro Q3 adjusted EPS $2.31 doubles YoY; U.S. Consumer sales up 11%
GAAP EPS $2.28 vs $0.77; Non-GAAP adjusted EPS $2.31 vs $1.17, more than doubling YoY.
-
ScottsMiracle-Gro Q2 GAAP EPS $2.74, adj. EPS $3.69; reaffirms FY2024 targets
Q2 net sales flat at $1.53B; U.S. Consumer record $1.38B (+2% YoY); Hawthorne down 28% to $66.4M.